Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-16-032094
Filing Date
2016-11-23
Accepted
2016-11-23 17:48:30
Documents
2
Period of Report
2016-11-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1762
2 ex24dorsch.txt EX-24 4326
  Complete submission text file 0001179110-16-032094.txt   7452
Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLUEPRINT MEDICINES CORPORATION 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address
Dorsch Marion (Reporting) CIK: 0001690460 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37359 | Film No.: 162017426